Lilly to pay $8bn for Loxo Oncology as cancer M&A soars

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Syndicated Loans
Investment Grade Loans

Lilly to pay $8bn for Loxo Oncology as cancer M&A soars

Mike Turner
January 07, 2019 02:15 PM
Cancer_cell_29March2017_Fotolia_230x150

Eli Lilly, the US pharmaceuticals company, has agreed to buy Loxo Oncology for around $8bn, as big ticket consolidation in the drug sector continues apace.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Deutsche BankSyndicated LoansInvestment Grade LoansSRIGoldman Sachs
MT
Mike Turner
Corporate Debt Editor
Contact
Gift this article